A Monotherapy in Subjects With Advanced Solid Tumors

NCT04221204 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: Highly selective FGFR1-3 inhibitor

Sponsor

3D Medicines (Beijing) Co., Ltd.